Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.